Seres’ drug fails in Phase IIb ulcerative colitis trial
The company will discontinue the open-label and maintenance portions of the ECO-RESET trial owing to no clinical efficacy signal.
News
Adagene partners with Merck on combination treatment for cancer
The agreement involves two Phase I trials to analyse the treatments’ safety, tolerability and recommended...
eFFECTOR begins dosing in Phase Ib trial of zotatifin in Covid-19
The safety and tolerability of the IV infusion of the drug candidate are the primary...
Humanigen’s partners get approval to trial lenzilumab in South Korea
Telcon and KPM will perform a Phase I trial of the antibody for Covid-19 treatment...
Sorrento doses subjects in Covid-19 trial of intranasal drug in the UK
The efficacy trial will enrol nearly 350 Covid-19 patients who have mild symptoms or are...
FAU team develops new method to forecast Covid-19 trial outcome
The study showed that computational techniques could help distinguish between finished and stopped Covid-19 trials.
FDA places clinical hold on Magenta’s Phase I/II leukaemia trial
The requirement for a bioassay to inform dose escalation was the only clinical hold factor identified.
Oravax to commence trials of oral Covid-19 vaccine in Israel
The VLP vaccine addresses three surface proteins of SARS CoV-2, which could allow its efficacy against viral variants.
India may deploy Covid-19 vaccine boosters: Brazil, South Africa unlikely to follow soon
There’s increasing talk of vaccine boosters to combat the Delta variant. But what does this mean in COVID-19 hotspots such as Brazil, South Africa, and India, where the different variants of concern first appeared?
UCLH commences trial of new Alzheimer’s drug candidate
E2814 is the first tau-targeting treatment to enter trials in people with an inherited form of Alzheimer’s.
Takeda reports data from Phase III von Willebrand disease trial
The rVWF prophylaxis decreased spontaneous, treated annualised bleeding rates by 91.5% in prior on-demand treatment patients.
